Mark Webb, PhD

Mark Webb, PhD has extensive work experience in the field of clinical research. Mark is currently employed at OnQuality Pharmaceuticals Ltd. as a Senior Clinical Research Manager since January 2021. Prior to this role, they served as a Clinical Research Manager at the same company from August 2019 to January 2021.

Before joining OnQuality Pharmaceuticals Ltd., Mark worked at PRA Health Sciences as a Senior Clinical Research Associate from November 2017 to August 2019. In this position, they focused on oncology studies as part of the Bayer program.

Mark began their career at Medpace in 2013 as a Clinical Research Associate (CRA IV). Mark worked on various therapeutic areas including hepatology, oncology, rare disease, autoimmunity, and pediatrics. Mark was involved in phase 1, 2, and 3 studies and also served as a Lead CRA, responsible for drafting and maintaining monitoring plans.

Mark's academic background includes being a Graduate Student at the University of Cincinnati from July 2007 to November 2013.

Mark Webb, PhD has a strong education background in the field of immunobiology. Mark obtained their Doctor of Philosophy (Ph.D.) degree in Immunobiology from the University of Cincinnati College of Medicine, where they studied from 2007 to 2013. Prior to that, they completed their Bachelor of Science (BS) degree in Microbiology at Brigham Young University, from 2001 to 2007. These educational experiences have provided him with a robust foundation in microbiology and immunobiology.